IBDEI2FD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41134,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,41134,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,41134,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,41135,0)
 ;;=R33.9^^159^2000^105
 ;;^UTILITY(U,$J,358.3,41135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41135,1,3,0)
 ;;=3^Urine Retention,Unspec
 ;;^UTILITY(U,$J,358.3,41135,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,41135,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,41136,0)
 ;;=R32.^^159^2000^103
 ;;^UTILITY(U,$J,358.3,41136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41136,1,3,0)
 ;;=3^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,41136,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,41136,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,41137,0)
 ;;=N39.41^^159^2000^101
 ;;^UTILITY(U,$J,358.3,41137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41137,1,3,0)
 ;;=3^Urge Incontinence
 ;;^UTILITY(U,$J,358.3,41137,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,41137,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,41138,0)
 ;;=R35.0^^159^2000^63
 ;;^UTILITY(U,$J,358.3,41138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41138,1,3,0)
 ;;=3^Micturition Frequency
 ;;^UTILITY(U,$J,358.3,41138,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,41138,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,41139,0)
 ;;=R35.1^^159^2000^73
 ;;^UTILITY(U,$J,358.3,41139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41139,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,41139,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,41139,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,41140,0)
 ;;=R39.11^^159^2000^64
 ;;^UTILITY(U,$J,358.3,41140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41140,1,3,0)
 ;;=3^Micturition Hesitancy
 ;;^UTILITY(U,$J,358.3,41140,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,41140,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,41141,0)
 ;;=R39.16^^159^2000^95
 ;;^UTILITY(U,$J,358.3,41141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41141,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,41141,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,41141,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,41142,0)
 ;;=R36.0^^159^2000^97
 ;;^UTILITY(U,$J,358.3,41142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41142,1,3,0)
 ;;=3^Urethral Discharge w/o Blood
 ;;^UTILITY(U,$J,358.3,41142,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,41142,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,41143,0)
 ;;=R36.9^^159^2000^98
 ;;^UTILITY(U,$J,358.3,41143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41143,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,41143,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,41143,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,41144,0)
 ;;=R97.2^^159^2000^27
 ;;^UTILITY(U,$J,358.3,41144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41144,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,41144,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,41144,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,41145,0)
 ;;=R80.1^^159^2000^87
 ;;^UTILITY(U,$J,358.3,41145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41145,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,41145,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,41145,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,41146,0)
 ;;=R80.0^^159^2000^85
 ;;^UTILITY(U,$J,358.3,41146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41146,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,41146,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,41146,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,41147,0)
 ;;=R80.8^^159^2000^88
 ;;^UTILITY(U,$J,358.3,41147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41147,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,41147,1,4,0)
 ;;=4^R80.8
